IEX Share Price | IDEX Corp. Stock Analysis & Recommendation

Q: How big is IDEX Corp.?

Market Cap: As of Jun 18, IDEX Corp. has a market capitalization of 15,746.96 million, classifying it as a Mid Cap company.Recent Quarterly Performance: For the latest four quarters, IDEX Corp. reported net sales of 3,282.60 million and a net profit of 478.70 million.Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 3,794.70 million, while total assets were reported at 6,745.30 million.

Q: What does IDEX Corp. do?

Overview:IDEX Corp. operates in the industrial manufacturing sector, providing applied solutions through the sale of pumps, flow meters, and fluidics systems, and is categorized as a mid-cap company.Financial Snapshot:Most recent Net Sales: 814 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 95 Million (Quarterly Results - Mar 2025) Market cap: USD 15,746.96 Million (Mid Cap)Key Metrics:P/E: 32.00 Dividend Yield: 133.47% Debt Equity: 0.35 Return on Equity: 12.96% Price to Book: 4.03 Contact Details:Address: 3100 Sanders Road, Suite 301, NORTHBROOK IL: 60062 Tel: 1 847 4987070 Fax: 1 302 6555049 Website: http://www.idexcorp.com

Q: Is IDEX Corp. technically bullish or bearish?

As of 10 October 2025, the technical trend for IDEX Corp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength, driven by the daily moving averages indicating bearishness, and the weekly and monthly KST and Bollinger Bands also showing bearish signals. The MACD is mildly bullish on the weekly but bearish on the monthly, while the RSI shows bullishness on the weekly but no signal on the monthly. In terms of performance, IDEX Corp. has underperformed the S&P 500 across multiple periods, with a year-to-date return of -23.15% compared to the S&P 500's 11.41%, and a one-year return of -23.95% versus 13.36% for the benchmark.

Q: Is IDEX Corp. overvalued or undervalued?

As of 17 October 2025, the valuation grade for IDEX Corp. has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued based on its P/E ratio of 32, which is significantly higher than the peer average of 29.59, and an EV to EBITDA ratio of 20.22 compared to the peer average of 17.87. Additionally, the Price to Book Value stands at 4.20, further supporting the notion of overvaluation in the context of its industry.In terms of peer comparison, IDEX Corp. shows a higher P/E and EV to EBITDA ratio than its peers, suggesting that investors are paying a premium for its earnings relative to similar companies. Notably, the company's recent performance has been underwhelming, with a year-to-date return of -20.54%, contrasting sharply with the S&P 500's return of 13.30% over the same period, which reinforces the perception of overvaluation.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

271.69 k

Shareholding (Dec 2025)

FII

29.65%

Held by 337 FIIs

DII

15.77%

Held by 66 DIIs

Promoter

0.02%

How big is IDEX Corp.?

22-Jun-2025

As of Jun 18, IDEX Corp. has a market capitalization of $15.75 billion, with net sales of $3.28 billion and a net profit of $478.7 million over the last four quarters.

View full answer

What does IDEX Corp. do?

22-Jun-2025

IDEX Corp. is a mid-cap industrial manufacturing company that specializes in pumps, flow meters, and fluidics systems, with recent net sales of $814 million and a net profit of $95 million. Key financial metrics include a P/E ratio of 32.00 and a dividend yield of 133.47%.

View full answer

Who are in the management team of IDEX Corp.?

22-Jun-2025

As of March 2022, the management team of IDEX Corp. includes Non-Executive Chairman William Cook, CEO Eric Ashleman, and Independent Directors Mark Beck, Mark Buthman, Carl Christenson, and Katrina Helmkamp, who oversee the company's strategic direction and operations.

View full answer

Is IDEX Corp. technically bullish or bearish?

14-Oct-2025

As of October 10, 2025, IDEX Corp. has shifted to a bearish trend with moderate strength, underperforming the S&P 500 significantly, showing a year-to-date return of -23.15% compared to the S&P 500's 11.41%.

View full answer

Is IDEX Corp. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, IDEX Corp. is considered overvalued with a P/E ratio of 32, an EV to EBITDA ratio of 20.22, and a Price to Book Value of 4.20, all exceeding peer averages, while its year-to-date return of -20.54% significantly lags behind the S&P 500's 13.30% return.

View full answer

Compare IDEX Corp. with Similar Stocks

Dover Corp.Xylem, Inc.Ingersoll Rand, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROCE of 17.96%

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.83 times

Poor long term growth as Operating profit has grown by an annual rate 4.78% of over the last 5 years

Negative results in Jun 25

With ROCE of 13.18%, it has a expensive valuation with a 3.37 Enterprise value to Capital Employed

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Industrial Manufacturing

Market cap

USD 16,735 Million (Mid Cap)

P/E

33.00

Industry P/E

Dividend Yield

96.54%

Debt Equity

0.31

Return on Equity

12.46%

Price to Book

4.16

Revenue and Profits:

Net Sales:

899 Million

(Quarterly Results - Dec 2025)

Net Profit:

128 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

6.34%

6 Months

19.95%

1 Year

3.53%

2 Years

-21.42%

3 Years

-12.67%

4 Years

-1.33%

5 Years

-4.82%

IDEX Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.01%

EBIT Growth (5y)

6.18%

EBIT to Interest (avg)

15.39

Debt to EBITDA (avg)

0.83

Net Debt to Equity (avg)

0.35

Sales to Capital Employed (avg)

0.61

Tax Ratio

21.43%

Dividend Payout Ratio

44.26%

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

17.96%

ROE (avg)

16.27%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.16

EV to EBIT

24.84

EV to EBITDA

19.33

EV to Capital Employed

3.40

EV to Sales

5.21

PEG Ratio

Dividend Yield

96.54%

ROCE (Latest)

13.69%

ROE (Latest)

12.46%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 137 Schemes (54.55%)

Foreign Institutions

Held by 337 Foreign Institutions (29.65%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 2.32% vs 1.54% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 0.47% vs -2.59% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "899.10",
          "val2": "878.70",
          "chgp": "2.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "239.90",
          "val2": "239.90",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "16.20",
          "val2": "16.50",
          "chgp": "-1.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "-2.00",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "128.30",
          "val2": "127.70",
          "chgp": "0.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "207.30%",
          "val2": "213.70%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.77% vs -0.16% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -4.38% vs -15.28% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,457.50",
          "val2": "3,268.80",
          "chgp": "5.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "931.10",
          "val2": "872.50",
          "chgp": "6.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "64.40",
          "val2": "44.50",
          "chgp": "44.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-25.30",
          "val2": "-19.70",
          "chgp": "-28.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "482.50",
          "val2": "504.60",
          "chgp": "-4.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "209.60%",
          "val2": "213.20%",
          "chgp": "-0.36%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

899.10

878.70

2.32%

Operating Profit (PBDIT) excl Other Income

239.90

Interest

16.20

16.50

-1.82%

Exceptional Items

-2.80

-2.00

-40.00%

Consolidate Net Profit

128.30

127.70

0.47%

Operating Profit Margin (Excl OI)

207.30%

213.70%

-0.64%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.32% vs 1.54% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 0.47% vs -2.59% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,457.50

3,268.80

5.77%

Operating Profit (PBDIT) excl Other Income

931.10

872.50

6.72%

Interest

64.40

44.50

44.72%

Exceptional Items

-25.30

-19.70

-28.43%

Consolidate Net Profit

482.50

504.60

-4.38%

Operating Profit Margin (Excl OI)

209.60%

213.20%

-0.36%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 5.77% vs -0.16% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -4.38% vs -15.28% in Dec 2024

All Annual Results

Company CV

About IDEX Corp.

IDEX Corp.

Industrial Manufacturing

IDEX Corporation (IDEX) operates an applied solutions business that sells pumps, flow meters and other fluidics systems, and components and engineered products. The Company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST) and Fire & Safety/Diversified Products (FSDP). Its FMT segment provides flow monitoring and other services for the food, chemical, water and wastewater, agricultural and energy industries. The HST segment designs and distributes precision fluidics, rotary lobe pumps, roll compaction and drying systems. Its FSDP segment produces firefighting pumps and controls, rescue tools, lifting bags and other components and systems; engineered stainless steel banding and clamping devices, and precision equipment. Its Fire & Safety platform provides Hurst Jaws of Life, which manufactures the rescue tools. It provides Band-IT platform, which designs and manufactures engineered fastening solutions.

Company Coordinates

Company Details

3100 Sanders Road, Suite 301 , NORTHBROOK IL : 60062

Tel: 1 847 49870701 847 4987070

http://www.idexcorp.com

Registrar Details